Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Active:	Yes
Cancer Type:	Cancer-Related Syndrome Leukemia Myelodysplastic Syndromes (MDS)	NCT ID:	NCT05320198
Trial Phases:	Phase I Phase II	Protocol IDs:	DISC-0974-102 (primary) NCI-2022-05581
Eligibility:	18 Years and older, Male and Female	Study Type:	Treatment
Study Sponsor:	Disc Medicine, Inc
NCI Full Details:	http://clinicaltrials.gov/show/NCT05320198

Summary

This phase 1b/2a open-label study will assess the safety, tolerability, pharmacokinetics
and pharmacodynamics of DISC-0974 as well as categorize the effects on anemia response in
subjects with myelofibrosis or myelodysplastic syndrome and anemia.

Treatment Sites in Georgia

Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
winshipcancer.emory.edu

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.